As the procedure involves the inspection of all (abnormal) reports by a laboratory specialist, all related diseases will be subject to this investigation.
Conditions
Interventions
Study design: a randomised clinical trial with reports with reflective testing vs. traditional reports. The randomisation of reports will be performed after the laboratory specialist has done the addi
Sponsors
Dr. Wytze P. Oosterhuis
Arts Klinische Chemie, Epidemioloog
Atrium Medisch Centrum Parkstad
Klinische Chemie
Postbus 4446
6401 CX Heerlen
Eligibility
Inclusion criteria
Inclusion criteria: The study will be restricted to those cases, in which abnormal test results require additional testing and/or comments, according to the laboratory specialist.
Exclusion criteria
Exclusion criteria: Cases in which there is substantial risk for the patient and normally (following the existing protocol) the lab would either send an urgent fax message to the practice or the laboratory specialist would directly make a telephone call to the general practitioner.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| In every case where a report with comments is generated (both in control and study groups), the following data will be collected: 1. Following laboratory reports; 2. Following treatments, referrals; 3. Other additional diagnostic procedures and patient data from the general practitioner. | — |
Secondary
| Measure | Time frame |
|---|---|
| A panel (consisting of medical specialists) will be asked to answer the following questions: 1. How useful were the additional tests and comments for the patient?; 2. What was the benefit for the patient in terms of health improvement?; 3. Was the treatment adequate in the control group, without additional information reported to the general practitioner? This will be graded from negative to positive. | — |
Contacts
Public ContactWilhelmine Verboeket-van de Venne
Atrium Medisch Centrum Parkstad Klinische Chemie Postbus 4446
Outcome results
None listed